Adaptimmune Therapeutics plc Analysis
| Analyst Ratings |
|
Average Target Price
|
5.88
|
|
Average Rating
|
4.00
|
|
# Strong Buys
|
4
|
|
# Buys
|
0
|
|
# Holds
|
2
|
|
# Sells
|
1
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2023-03-31
|
-0.20
|
0.00
|
0.20
|
100.00%
|
|
2022-12-31
|
-0.24
|
0.00
|
0.24
|
100.00%
|
|
2022-09-30
|
-0.24
|
-0.24
|
0.00
|
0.00%
|
|
2022-06-30
|
-0.24
|
-0.28
|
-0.04
|
-16.67%
|
|
2022-03-31
|
-0.22
|
-0.30
|
-0.08
|
-36.36%
|
|
2021-12-31
|
0.14
|
-0.24
|
-0.38
|
-271.43%
|
|
2021-09-30
|
-0.26
|
-0.30
|
-0.04
|
-15.38%
|
|
2021-06-30
|
-0.24
|
-0.24
|
0.00
|
0.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.82
|
|
2021-12-31
|
-1.02
|
|
2020-12-31
|
-0.96
|
|
2019-12-31
|
-1.31
|
|
2018-12-31
|
-1.00
|
|
2017-12-31
|
-0.85
|
|
2016-12-31
|
-1.00
|
|
2015-12-31
|
-0.18
|